Upload
others
View
11
Download
3
Embed Size (px)
Citation preview
BLEEDING DISORDERS
By
Diaa Ahmed Elsaied
Lecturer OMFS Minia University
Leukopenia :
Deficient WBC , Decrease of neutrophils is most common etiology .
Physical finding are increased risk microbial infection.
Increased risk of fungal infection.
Management include :
-- Prophylactic Antibiotic.
Elevated percentage of immature WBC in peripheral circulation.
It is cancer of the WBCs that affects the bone marrow and circulating blood. It involves exponential proliferation of a clonal myeloid or lymphoid cell.
Symptoms includes:
Nausea – Fever – Weight Loss
Fatigue – Malaise - Epistaxix
Liver or spleen enlargment Bone pain & tenderness
Oral manifestation includes:
Gingival Enlargement & ulceration
Pain Erythema & oral infection
The cause of leukemia is unknown
Increased risk is associated with large doses of ionizing
radiation, certain chemicals(benzene), and infection with
specific viruses [EPV] and human lymphotropic virus
[HTLV]-1
Smoking & exposure to electromagnetic
Genetic factors may cause cytogenetic abnormalities that
affect transcriptional cascades of myeloid precursor cells.
Acute leukemia
Result from accumulation of immature , functionless WBCs in the marrow & blood
1. Acute myeloid leukemia (AML)
2. Acute lymphocytic leukemia (ALL)
Chronic leukemia
Have slower onset which allows production of larger numbers of more mature, functional cells
1. Chronic myeloid leukemia (CML)
2. Chronic lymphocytic leukemia (CLL)
Bone marrow test
1. Bone marrow aspiration :
Remove a liquid marrow sample
2. Bone marrow biopsy
Lumbar puncture:
Removes a small amount of
cerebrospinal fluid (CSF) from the space around the spine
Chemotherapy
The main treatment for many kinds of leukemia
It has 3 phases:
1- Induction
2- Consolidation
3- Maintenance
Radiation therapy
To prevent leukemia from spreading to, or treat leukemia that has spread to, the central nervous system (CNS)
Bone marrow transplant
LEUKEMIA
Anemia is a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood, or a lowered ability of the blood to carry oxygen.
Laboratory definition:
Reduction in haemoglobin concentration
below normal
WHO criteria:
Males Hgb <13 gm/dl,
Females Hgb <12gm/dl
Symptoms:
Fatigue Weakness Dyspnea Palpitation
Headache Dizziness Angina Tinnitus
Signs:
Pallor Tachycardia Cardiac Failure
Medical & family history & perform a physical exam.
Complete blood count (CBC):- A CBC is used to count the number of blood cells in a sample of your blood. For anemia the levels of the red blood cells contained in the blood (hematocrit) and the hemoglobin in the blood is interested.
Tests for internal bleeding:- To ensure that internal bleeding is causing anemia, may also perform an endoscopy. These test can help identify sources of gastrointestinal bleeding.
Treatments for anemia depend on cause and severity. Vitamin supplements given orally (folic acid or vitamin B12) or intramuscularly (vitamin B12) will replace specific deficiencies.
Anemia treatment depends on the cause.
a) Iron deficiency anemia
b) Vitamin deficiency anemia
c) Anemia of chronic disease
d) Aplastic anemia
e) Anemia associated with bone marrow disease
f) Hemolytic anemia
g) Sickle cell anemia
Iron deficiency anemia:- Treatment for this form of anemia usually involves taking iron supplements & making changes to your diet.
• Diet as red meat, dark green leafy vegetables, dried fruits, nuts, iron-fortified cereals.
Vitamin deficiency anemia:- Treatment for folic acid & B-12 deficiency involves dietary supplements & increasing these nutrients in diet.
•If your digestive system has trouble absorbing vitamin B-12 from the food you eat, you may need vitamin B-12 shots.
Platelets Phase:
Platelet Count
Bleeding Time (BT)
Platelets Funtion Analyzer (PFA)
Coagulation Phase:
Prothrombin Time (PT)
Partial Thromboplastin Time (PTT)
Thrombin Time (TT)
NORMAL 100,000 - 400,000 CELLS/MM3
,
< 100,000 Thrombocytopenia
50,000 - 100,000 Mild Thrombocytopenia
< 50,000 Sever Thrombocytopenia
Provides Assessment Of Platelet Count & function (Quantitative & Qualitative)
NORMAL VALUE
2-8 Min
Quntative lab test for platelets function & avoid variability of BT
Normal < 193 s
Measures Effectiveness of the Extrinsic Pathway
Mnemonic - PET
NORMAL VALUE
11- 14 SECS
Measures Effectiveness of the Intrinsic
Pathway
Mnemonic - PITT
NORMAL VALUE
27 – 38 SECS
Time for Thrombin To Convert
Fibrinogen Fibrin
A Measure of Fibrinolytic Pathway
NORMAL VALUE
9-13 SECS
Dental management of the medically compromised patient
PT, aPTT, TT, BT History bleeding problem
BT, aPTT Aspirin therapy
PT Coumarin therapy
aPTT Renal dialysis (heparin)
BT – PT Possible liver disease
BT Chronic leukemia
PT Long term antibiotic therapy
BT Vascular wall alteration
TT Cancer (fibrinogenolysis)
TT PT PTT BT Platelet count Condition
- + + + + Aspirin therapy
- ++ ++ - - Coumarin therapy
- - ++ + + Heparin therapy
++ ++ ++ + + Liver disease
- - - + + Leukemia
++ ++ ++ - - Long term antibiotic
- - - + - Vascular wall defect
- - - ++ ++ Thrombocytopenia
- - ++ - - Hemophilia
++ + + - - Fibrinogenolysis
- normal, + may be abnormal, ++ abnormal
GOOD THOROUGH MEDICAL HISTORY
A PHYSICAL EXAMINATION
SCREENING CLINICAL LAB TESTS
EXCESSIVE BLEEDING FOLLOWING SURGICAL
PROCEDURE
Family HX
Personal HX
Medications
Past & Present Illness
Spontaneous Bleeding
FIVE DRUGS THAT INTERFERE WITH HEMOSTASIS
ASPIRIN
ANTICOAGULANTS
ANTIBIOTICS
ALCOHOL
ANTICANCER
Petechiae & Ecchymosis
Gingival Hyperplasia
Spontaneous Gingival Bleeding
Ulceration of Oral Mucosa
Lymphadenopathy
LOW RISK
Patients with No Hx of Bleeding Disorders
Normal Laboratory Results
MODERATE RISK
Patients on Chronic Oral Anticoagulant
Therapy. PT is 1.5 - 2 Times Control Range
Patients on Chronic Aspirin Therapy
HIGH RISK
Patients with Known Bleeding Disorders
Patients without Known Bleeding Disorders
Who Have Abnormal Laboratory Results
LOW RISK PATIENTS
Normal Protocol
MODERATE RISK PATIENTS
Anticoagulants - Consult Physician
Aspirin Therapy - BT, Consult Physician
HIGH RISK PATIENTS
Close Coordination with Physician
Hospitalization (Platelet Transfusion)
(Factor Replacement)
(Vit K Therapy)
(Dialysis)